Michael Paulzen

Aachen, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 120 publications

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2026 - Pharmacokinetic, pharmacogenetic and clinical aspects.

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2026 - Pharmacokinetic, pharmacogenetic and clinical aspects.

Journal: Pharmacopsychiatry

Published: July 02, 2026

Cardiovascular adverse drug reactions related to psychotropic drugs: an evaluation of data of summaries of product characteristics

Cardiovascular adverse drug reactions related to psychotropic drugs: an evaluation of data of summaries of product characteristics

Journal: Fortschritte der Neurologie-Psychiatrie

Published: May 21, 2026

Dextromethorphan-bupropion for the treatment of agitation in Alzheimer's disease

Dextromethorphan-bupropion for the treatment of agitation in Alzheimer's disease

Journal: Der Nervenarzt

Published: May 08, 2026

Optimisation of psychopharmacological treatment strategies by using therapeutic drug monitoring

Optimisation of psychopharmacological treatment strategies by using therapeutic drug monitoring

Journal: Therapeutische Umschau. Revue therapeutique

Published: March 25, 2026

Effects of antidepressant treatment on fetal development and obstetric complications: a retrospective ultrasound study.

Effects of antidepressant treatment on fetal development and obstetric complications: a retrospective ultrasound study.

Journal: Journal of psychiatric research

Published: March 17, 2026

Olanzapine long acting injectable in new application form-Hope for the absence of post-injection delirium/sedation syndromes

Olanzapine long acting injectable in new application form-Hope for the absence of post-injection delirium/sedation syndromes

Journal: Der Nervenarzt

Published: March 06, 2026

All about nothing? What about the risk for developmental disorders in offsprings after paternal exposure with valproic acid?

All about nothing? What about the risk for developmental disorders in offsprings after paternal exposure with valproic acid?

Journal: Der Nervenarzt

Published: December 01, 2025

Utility of therapeutic drug monitoring in the treatment of major depressive disorder.

Utility of therapeutic drug monitoring in the treatment of major depressive disorder.

Journal: Current opinion in psychiatry

Published: November 06, 2025

Dealing with the impact of pregnancy on the pharmacokinetics of aripiprazole once-monthly.

Dealing with the impact of pregnancy on the pharmacokinetics of aripiprazole once-monthly.

Journal: Archives of women's mental health

Published: November 05, 2025

Plea for an appropriately dosed antipsychotic psychopharmacotherapy using haloperidol as an example

Plea for an appropriately dosed antipsychotic psychopharmacotherapy using haloperidol as an example

Journal: Der Nervenarzt

Published: October 14, 2025

SARS-CoV-2 vaccination and plasma levels of psychotropic agents: a prospective cohort study.

SARS-CoV-2 vaccination and plasma levels of psychotropic agents: a prospective cohort study.

Journal: Expert opinion on drug metabolism & toxicology

Published: October 14, 2025

Z-drugs and the risk of sleep driving

Z-drugs and the risk of sleep driving

Journal: Der Nervenarzt

Published: September 17, 2025

Showing 1-12 of 120

Last Updated: 09/26/2026